We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Tau Proteins Visualized While Neurons Are “Talking”

Tau clusters identified in a live neuron under a microscope.
Credit: QBI Shanley Longfield.
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

For the first time, University of Queensland (UQ) researchers have shown how the tau protein, known for its role in dementias, behaves where communication in the brain takes place.


The study led by Dr Ramón Martínez-Mármol and PhD student Shanley Longfield from UQ’s Queensland Brain Institute used super-resolution microscopy to visualise individual tau proteins in motion while neurons are “talking” to each other.


Dr Martínez-Mármol explained that the team’s discovery is a big step towards understanding what triggers tau aggregation in disease states like Alzheimer’s disease.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

“We discovered that tau in a healthy brain controls an important population of vesicles at the presynapse critical for neuronal communication,” Dr Martínez-Mármol said.


“These vesicles are like the words that neurons use to transmit information to other neurons.


"For the very first time, we’ve shed light on the mechanism by which tau acts in our nerve cells.


“By understanding tau’s role in a healthy context, we begin to fully understand what leads to the abnormal accumulation of tau in disease.”


Ms Longfield said that observing tau’s behaviour in healthy states provides clues to how these toxic aggregates start to form.


“Studying tau in a healthy brain is more challenging than studying it in a diseased brain, where changes in its molecular behaviour are far more prominent and obvious,” Ms Longfield said.


“But by visualising tau at the nanoscale and in this context, we can identify the molecular behaviours that precede the formation of toxic protein aggregates in disease.”


The team also discovered that tau molecules form tiny condensates, dense gel-like bodies within brain cells, which resemble oil droplets suspended in water.


“What we noticed is that these tau condensates are very fluid-like and dynamic and are tightly regulated by synaptic activity,” Ms Longfield said.


“In neurodegenerative disorders, these condensates get bigger and denser and eventually form aggregates, which are destructive to brain function.


“Our next challenge is to track diseased tau in brain cells to see how this new function is altered, leading to tau aggregation.”


Reference: Longfield SF, Mollazade M, Wallis TP, et al. Tau forms synaptic nano-biomolecular condensates controlling the dynamic clustering of recycling synaptic vesicles. Nat Commun. 2023;14(1):7277. doi: 10.1038/s41467-023-43130-4


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.